Evidence mapPaperPMID 39079139Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2024

Glycemic control and study of lipid and bone metabolism in type 1 diabetic children

Pilar Calmarza, Rasha Isabel Pérez-Ajami, Carlos Prieto-López, Alba Gallego-Royo, Celia García-Carro, Graciela María Lou-Francés

Abstract readEnglish Abstract
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pilar CalmarzaServicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, España; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Universidad de Zaragoza, Zaragoza, España; Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, España.ORCID 0000-0003-3717-8227
Rasha Isabel Pérez-AjamiServicio de Pediatría, Hospital Universitario Miguel Servet, Zaragoza, España.ORCID 0000-0002-9610-8053
Carlos Prieto-LópezServicio de Bioquímica Clínica, Hospital de Alcañiz, Alcañiz, España.ORCID 0000-0001-7889-8058
Alba Gallego-RoyoServicio de Medicina Preventiva, Hospital Universitario Miguel Servet, Zaragoza, España.ORCID 0000-0003-4727-7624
Celia García-CarroServicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, España.ORCID 0009-0008-1311-680X
Graciela María Lou-FrancésCentro de Salud de Barbastro, Barbastro, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. Type 1 diabetes mellitus is considered one of the most common chronic diseases of childhood. It is a high-risk factor for developing early cardiovascular disease and it also affects bone health. Objective. To describe demographic characteristics and biochemical parameters of a population of children with type 1 diabetes, evaluated in the pediatric diabetes unit of a tertiary Spanish hospital. Materials and methods. In this retrospective study, we determined metabolic, lipid, and bone parameters in 124 children with type 1 diabetes who were monitored in the pediatric diabetes unit of the Hospital Universitario Miguel Servet in Zaragoza (Spain) from May 2020 to July 2021. Results. Children with type 1 diabetes have worse metabolic control of the disease at puberty, but their lipid control is considered acceptable. We found an inverse correlation between bone formation markers and disease duration, as well as with metabolic control. Conclusion. Bone formation markers are inversely correlated with the percentage of glycated hemoglobin and diabetes evolution time. Patients’ lipid and bone profiles are more favorable when metabolic control of the disease is achieved.

Indexed as

Bone and BonesDiabetes Mellitus, Type 1Glycated HemoglobinGlycemic ControlAdolescentBiomarkersChildChild, PreschoolFemaleHumansLipid MetabolismMaleOsteogenesisRetrospective StudiesBiomarkersGlycated HemoglobinchildrenDiabetes mellitusglycated hemoglobinlipidsosteocalcintype 1

Identifiers

PMID39079139
PMCPMC11361410

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.